Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial

We evaluated the efficacy of the human papillomavirus (HPV)−16/18 AS04‐adjuvanted vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc analysis of the PApilloma TRIal against Cancer In young Adults (PATRICIA; NCT00122681). Healthy women aged 15–25 years were ran...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Cancer
Autori principali: Garland, Suzanne M., Paavonen, Jorma, Jaisamrarn, Unnop, Naud, Paulo, Salmerón, Jorge, Chow, Song‐Nan, Apter, Dan, Castellsagué, Xavier, Teixeira, Júlio C., Skinner, S. Rachel, Hedrick, James, Limson, Genara, Schwarz, Tino F., Poppe, Willy A.J., Bosch, F. Xavier, de Carvalho, Newton S., Germar, Maria Julieta V., Peters, Klaus, Del Rosario‐Raymundo, M. Rowena, Catteau, Grégory, Descamps, Dominique, Struyf, Frank, Lehtinen, Matti, Dubin, Gary
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Cancer Therapy and Prevention
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412942/
https://ncbi.nlm.nih.gov/pubmed/27541373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30391
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi